ArticleReviews in cardiovascular medicine2023

Clinical Effectiveness and Safety Comparison between Reduced Rivaroxaban Dose and Dual Antiplatelet Therapy for Nonvalvular Atrial Fibrillation Patients Following Percutaneous Left Atrial Appendage Closure: A Prospective Observational Study.

Xiaoye Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.